Published in Gene Therapy Weekly, April 22nd, 2010
"Three indirect sigmaNS enzyme-linked immunosorbent assays (ELISAs), sigmaNS-ELISA, P17-ELISA and sigmaNS-P17-ELISA were optimized and used as specific tests. Serum samples from reovirus-infected and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2010-04-22)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.